Dr Candace Sue Kasper, MD in Carrollton, TX - Pathology

Dr Candace Sue Kasper, MD is a Pathology - Dermatopathology physician based in Carrollton, Texas. Dr Candace Sue Kasper is licensed to practice in Texas (license number F9650) and her current practice location is 2840 Keller Springs Rd, Suite 1104, Carrollton, Texas. She can be reached at her office (for appointments etc.) via phone at (214) 483-2100.

NPI number for Dr Candace Sue Kasper is 1689616450 and her current mailing address is 2840 Keller Springs Rd, Suite 1104, Carrollton, Texas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1689616450.

Contact Information

	Dr Candace Sue Kasper, MD
	2840 Keller Springs Rd, Suite 1104, Carrollton, TX 75006-4829
	(214) 483-2100
	(214) 483-2104

Physician's Profile

Full Name	Dr Candace Sue Kasper
Gender	Female
Speciality	Pathology - Dermatopathology
Location	2840 Keller Springs Rd, Carrollton, Texas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1689616450
Provider Enumeration Date: 06/13/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Candace Sue Kasper such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1689616450	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZD0900X	Pathology - Dermatopathology	F9650 (Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Candace Sue Kasper is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Candace Sue Kasper, MD 2840 Keller Springs Rd, Suite 1104, Carrollton, TX 75006-4829 Ph: (214) 483-2100	Dr Candace Sue Kasper, MD 2840 Keller Springs Rd, Suite 1104, Carrollton, TX 75006-4829 Ph: (214) 483-2100

News Archive

Additional benefits of LAIAs over long-acting human insulin not been proven

It has so far not been proven that the long-acting insulin analogues (LAIAs) insulin detemir (trade name: Levemir) and insulin glargine (trade name: Lantus), which are approved for the treatment of type 1 diabetes, offer patients an additional benefit versus long-acting human insulin. This applies to adults as well as to children and adolescents. This is the result of the final report published by the Institute for Quality and Efficiency in Health Care (IQWiG) on 19 April 2010.

Study suggests continued delta variant outbreaks unless vaccination reaches high coverage levels in adults and children

Researchers have conducted a mathematical modeling study to understand how expanding vaccination to younger age groups may reduce the increasing case numbers.

CDI, iPS Academia Japan announce licensing agreement for seminal iPSC patent portfolio

Cellular Dynamics International, Inc. (CDI), the world's largest producer of cellular tools for drug discovery and safety derived from induced pluripotent stem cells (iPSCs), and iPS Academia Japan, Inc., today announced a nonexclusive licensing agreement for the seminal iPSC patent portfolio arising out of the work of Dr. Shinya Yamanaka, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University.

Public-private partnerships can help improve nutrition worldwide

InterAction President and CEO Sam Worthington, as part of a series organized by the Chicago Council On Global Affairs' Global Agriculture Development Initiative and InterAction to highlight the importance of public-private partnerships in agricultural development, writes in the Chicago Council's "Global Food for Thought" blog that recent figures showing one in eight people in the world is undernourished is "a call to collective action."

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ: APCVZ), announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market penicillin G potassium for Injection, USP, in two dosage strengths. Penicillin G is therapeutically equivalent to the reference drug PfizerPen™ G, which is marketed by the innovator Pfizer, Inc.

Pathology Doctors in Carrollton, TX

Dr. Michael W Robles, DO
Pathology
Medicare: Medicare Enrolled
Practice Location: 3418 Midcourt Rd, Suite 118, Carrollton, TX 75006
Phone: 214-420-8200

Dr Candace Sue Kasper, MD - Pathology in Carrollton, TX